TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 91 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,855,000 | -17.6% | 21,096 | -29.3% | 0.05% | -5.6% |
| Q3 2019 | $2,251,000 | +8.7% | 29,829 | +23.1% | 0.05% | +20.0% |
| Q2 2019 | $2,070,000 | -5.7% | 24,239 | +19.3% | 0.04% | -6.2% |
| Q1 2019 | $2,195,000 | +44.0% | 20,311 | +12.8% | 0.05% | +20.0% |
| Q4 2018 | $1,524,000 | -12.5% | 18,004 | +1.4% | 0.04% | +11.1% |
| Q3 2018 | $1,741,000 | -30.7% | 17,759 | -18.6% | 0.04% | -25.0% |
| Q2 2018 | $2,514,000 | +50.4% | 21,816 | +28.8% | 0.05% | +37.1% |
| Q1 2018 | $1,672,000 | -2.7% | 16,938 | +3.3% | 0.04% | -5.4% |
| Q4 2017 | $1,719,000 | – | 16,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |